ConforMIS Inc (CFMS.OQ)
CFMS.OQ on NASDAQ Stock Exchange Global Select Market
1.58USD
23 Apr 2018
1.58USD
23 Apr 2018
Change (% chg)
$-0.21 (-11.73%)
$-0.21 (-11.73%)
Prev Close
$1.79
$1.79
Open
$1.81
$1.81
Day's High
$1.81
$1.81
Day's Low
$1.57
$1.57
Volume
140,688
140,688
Avg. Vol
121,278
121,278
52-wk High
$5.95
$5.95
52-wk Low
$1.15
$1.15
About
ConforMIS, Inc. is a medical technology company. The Company uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants, which are individually sized and shaped, to fit each patient's anatomy. The Company's iFit technology platform is applicable to various joints. It offers a... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $108.91 |
| Shares Outstanding(Mil.): | 60.84 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CFMS.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 35.59 | 33.60 |
| EPS (TTM): | -1.24 | -- | -- |
| ROI: | -59.70 | 14.13 | 13.19 |
| ROE: | -76.21 | 16.91 | 15.00 |
BRIEF-Conformis Q4 Loss Per Share $0.27
* CONFORMIS REPORTS FOURTH QUARTER AND THE YEAR ENDED 2017 FINANCIAL RESULTS; REITERATES 2018 FINANCIAL GUIDANCE
BRIEF-Conformis - Expects Gross Profit Of About $28.8 Mln For Year Ended Dec 31, 2017
* CONFORMIS - GROSS PROFIT EXPECTED TO BE ABOUT $28.8 MILLION OR ABOUT 37% OF REVENUE, FOR YEAR ENDED DECEMBER 31, 2017-SEC FILING
BRIEF-ConforMIS Sees FY 2018 Revenue $79.6 Mln To $83.6 Mln
* SEES Q4 TOTAL REVENUE OF ABOUT $20.8 MILLION, DOWN 4% YEAR-OVER-YEAR ON A REPORTED BASIS
BRIEF-Conformis Q3 loss per share $0.29
* Q3 earnings per share view $-0.31 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:
Competitors
| Price | Chg | |
|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH.N) | $111.24 | +0.92 |
| Johnson & Johnson (JNJ.N) | $126.83 | +0.17 |
| Smith & Nephew plc (SN.L) | 1,389.00 | +37.00 |
| Stryker Corporation (SYK.N) | $166.78 | +2.53 |
Estimates